V

Vaxart
D

VXRT

0.81290
USD
0.05
(5.96%)
Market Closed
Volume
11,530
EPS
-1
Div Yield
-
P/E
-2
Market Cap
184,918,338
Related Instruments
    A
    APDN
    -0.00730
    (-4.03%)
    0.17370 USD
    AZN
    AZN
    0.265
    (0.39%)
    68.205 USD
    BNTX
    BNTX
    -2.010
    (-1.71%)
    115.330 USD
    C
    CODX
    0.04950
    (6.20%)
    0.84780 USD
    I
    INO
    0.06500
    (2.96%)
    2.26000 USD
    MRNA
    MRNA
    2.600
    (7.24%)
    38.490 USD
    N
    NVAX
    0.02500
    (0.28%)
    8.84500 USD
    PFE
    PFE
    -0.621
    (-2.33%)
    26.015 USD
    REGN
    REGN
    -7.47
    (-1.09%)
    679.85 USD
    V
    VIR
    0.090
    (0.86%)
    10.520 USD
    VRTX
    VRTX
    0.08
    (0.02%)
    428.09 USD
    More
News

Title: Vaxart

Sector: Healthcare
Industry: Biotechnology
Vaxart Inc is a clinical-stage biotechnology company. It focuses on the development of oral recombinant vaccines to protect against a wide range of infectious diseases. The products under its tablet pipeline consist of the treatment of Coronavirus, Norovirus, Seasonal Influenza, RSV(respiratory syncytial virus), and HPV(Human papillomavirus) Therapeutic. It operates in a single segment, which is the discovery and development of oral recombinant protein vaccines. Geographically all the business activity functions through the region of the United States.
Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.